535 related articles for article (PubMed ID: 10193651)
1. Effects of some AMPA receptor antagonists on the development of tolerance in epilepsy-prone rats and in pentylenetetrazole kindled rats.
De Sarro G; Di Paola ED; Gareri P; Gallelli L; Scotto G; De Sarro A
Eur J Pharmacol; 1999 Mar; 368(2-3):149-59. PubMed ID: 10193651
[TBL] [Abstract][Full Text] [Related]
2. Lack of development of tolerance to anticonvulsant effects of two excitatory amino acid antagonists, CGP [corrected] 37849 and CGP 39551 in genetically epilepsy-prone rats.
De Sarro G; De Sarro A; Ammendola D; Patel S
Brain Res; 1996 Sep; 734(1-2):91-7. PubMed ID: 8896813
[TBL] [Abstract][Full Text] [Related]
3. Synthesis and anticonvulsant activity of novel and potent 2,3-benzodiazepine AMPA/kainate receptor antagonists.
Grasso S; De Sarro G; De Sarro A; Micale N; Zappalà M; Puia G; Baraldi M; De Micheli C
J Med Chem; 1999 Oct; 42(21):4414-21. PubMed ID: 10543885
[TBL] [Abstract][Full Text] [Related]
4. Evidence for a unique profile of levetiracetam in rodent models of seizures and epilepsy.
Klitgaard H; Matagne A; Gobert J; Wülfert E
Eur J Pharmacol; 1998 Jul; 353(2-3):191-206. PubMed ID: 9726649
[TBL] [Abstract][Full Text] [Related]
5. 1-Aryl-3,5-dihydro-4H-2,3-benzodiazepin-4-ones: novel AMPA receptor antagonists.
Chimirri A; De Sarro G; De Sarro A; Gitto R; Grasso S; Quartarone S; Zappalà M; Giusti P; Libri V; Constanti A; Chapman AG
J Med Chem; 1997 Apr; 40(8):1258-69. PubMed ID: 9111300
[TBL] [Abstract][Full Text] [Related]
6. Preclinical evaluation of CHF3381 as a novel antiepileptic agent.
Villetti G; Bregola G; Bassani F; Bergamaschi M; Rondelli I; Pietra C; Simonato M
Neuropharmacology; 2001 Jun; 40(7):866-78. PubMed ID: 11378157
[TBL] [Abstract][Full Text] [Related]
7. Relationship between anticonvulsant activity and plasma level of some 2,3-benzodiazepines in genetically epilepsy-prone rats.
De Sarro G; Rizzo M; Sinopoli VA; Gitto R; De Sarro A; Zappala M; Chimirri A
Pharmacol Biochem Behav; 1998 Nov; 61(3):215-20. PubMed ID: 9768555
[TBL] [Abstract][Full Text] [Related]
8. Seizure susceptibility to various convulsant stimuli in dystrophin-deficient mdx mice.
De Sarro G; Ibbadu GF; Marra R; Rotiroti D; Loiacono A; Donato Di Paola E; Russo E
Neurosci Res; 2004 Sep; 50(1):37-44. PubMed ID: 15288497
[TBL] [Abstract][Full Text] [Related]
9. Anticonvulsant activity and plasma level of 2,3-benzodiazepin-4-ones (CFMs) in genetically epilepsy-prone rats.
De Sarro G; Rizzo M; Spagnolo C; Gitto R; De Sarro A; Scotto G; Zappala M; Chimirri A
Pharmacol Biochem Behav; 1999 Aug; 63(4):621-7. PubMed ID: 10462191
[TBL] [Abstract][Full Text] [Related]
10. Tolerance to anticonvulsant effects of some benzodiazepines in genetically epilepsy prone rats.
De Sarro G; Di Paola ED; Aguglia U; de Sarro A
Pharmacol Biochem Behav; 1996 Sep; 55(1):39-48. PubMed ID: 8870036
[TBL] [Abstract][Full Text] [Related]
11. Anticonvulsant effect of felbamate in the pentylenetetrazole kindling model of epilepsy in the rat.
Giorgi O; Carboni G; Frau V; Orlandi M; Valentini V; Feldman A; Corda MG
Naunyn Schmiedebergs Arch Pharmacol; 1996 Jul; 354(2):173-8. PubMed ID: 8857594
[TBL] [Abstract][Full Text] [Related]
12. The AMPA/kainate receptor antagonist, LY 300164, increases the anticonvulsant effects of diazepam.
Borowicz KK; Kleinrok Z; Czuczwar SJ
Naunyn Schmiedebergs Arch Pharmacol; 2000 Jun; 361(6):629-35. PubMed ID: 10882038
[TBL] [Abstract][Full Text] [Related]
13. Anticonvulsant effect of flutamide on seizures induced by pentylenetetrazole: involvement of benzodiazepine receptors.
Ahmadiani A; Mandgary A; Sayyah M
Epilepsia; 2003 May; 44(5):629-35. PubMed ID: 12752460
[TBL] [Abstract][Full Text] [Related]
14. Effects of YM90K, a selective AMPA receptor antagonist, on amygdala-kindling and long-term hippocampal potentiation in the rat.
Kodama M; Yamada N; Sato K; Kitamura Y; Koyama F; Sato T; Morimoto K; Kuroda S
Eur J Pharmacol; 1999 Jun; 374(1):11-9. PubMed ID: 10422635
[TBL] [Abstract][Full Text] [Related]
15. 3,5-Dihydro-4H-2,3-benzodiazepine-4-thiones: a new class of AMPA receptor antagonists.
Chimirri A; De Sarro G; De Sarro A; Gitto R; Quartarone S; Zappalà M; Constanti A; Libri V
J Med Chem; 1998 Aug; 41(18):3409-16. PubMed ID: 9719593
[TBL] [Abstract][Full Text] [Related]
16. Enhanced susceptibility of pentylenetetrazole kindled mice to quinolone effects.
De Sarro A; Naccari F; De Sarro G
Int J Antimicrob Agents; 1999 Aug; 12(3):239-44. PubMed ID: 10461842
[TBL] [Abstract][Full Text] [Related]
17. Anticonvulsant profile of valrocemide (TV1901): a new antiepileptic drug.
Isoherranen N; Woodhead JH; White HS; Bialer M
Epilepsia; 2001 Jul; 42(7):831-6. PubMed ID: 11488880
[TBL] [Abstract][Full Text] [Related]
18. Anticonvulsant activity of the cyclooxygenase-2 (COX-2) inhibitor etoricoxib in pentylenetetrazole-kindled rats is associated with memory impairment.
Katyal J; Kumar H; Gupta YK
Epilepsy Behav; 2015 Mar; 44():98-103. PubMed ID: 25660085
[TBL] [Abstract][Full Text] [Related]
19. [Effect of citicoline on the development of chronic epileptization of the brain (pentylenetetrazole kindling) and acute seizures reaction of kindled mice C57Bl/6].
Kuznetzova LV; Karpova MN; Zinkovsky KA; Klishina NV
Patol Fiziol Eksp Ter; 2014; (3):4-8. PubMed ID: 25536784
[TBL] [Abstract][Full Text] [Related]
20. Synthesis and evaluation of pharmacological and pharmacokinetic properties of 11H-[1,2,4]triazolo[4,5-c][2,3]benzodiazepin-3(2H)-ones.
Zappalà M; Gitto R; Bevacqua F; Quartarone S; Chimirri A; Rizzo M; De Sarro G; De Sarro A
J Med Chem; 2000 Dec; 43(25):4834-9. PubMed ID: 11123993
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
